BioCryst Pharmaceuticals Statistics

Total Valuation

BMV:BCRX has a market cap or net worth of MXN 29.07 billion. The enterprise value is 37.63 billion.

Market Cap	29.07B
Enterprise Value	37.63B

Important Dates

The next estimated earnings date is Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	209.92M
Shares Outstanding	n/a
Shares Change (YoY)	+1.84%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	1.03%
Owned by Institutions (%)	87.38%
Float	180.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.50
PS Ratio	2.64
PB Ratio	-4.09
P/TBV Ratio	n/a
P/FCF Ratio	33.12
P/OCF Ratio	31.58
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.04, with an EV/FCF ratio of 42.87.

EV / Earnings	-233.69
EV / Sales	3.45
EV / EBITDA	25.04
EV / EBIT	26.74
EV / FCF	42.87

Financial Position

The company has a current ratio of 1.87

Current Ratio	1.87
Quick Ratio	1.60
Debt / Equity	n/a
Debt / EBITDA	8.27
Debt / FCF	14.27
Interest Coverage	0.87

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	10.31%
Return on Invested Capital (ROIC)	14.46%
Return on Capital Employed (ROCE)	30.20%
Revenue Per Employee	18.97M
Profits Per Employee	-277,631
Employee Count	580
Asset Turnover	1.28
Inventory Turnover	29.60

Taxes

In the past 12 months, BMV:BCRX has paid 39.66 million in taxes.

Income Tax	39.66M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.34%
50-Day Moving Average	250.57
200-Day Moving Average	n/a
Relative Strength Index (RSI)	43.93
Average Volume (20 Days)	541

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.47

Income Statement

In the last 12 months, BMV:BCRX had revenue of MXN 11.00 billion and -161.03 million in losses. Loss per share was -0.83.

Revenue	11.00B
Gross Profit	7.53B
Operating Income	1.42B
Pretax Income	-121.37M
Net Income	-161.03M
EBITDA	1.48B
EBIT	1.42B
Loss Per Share	-0.83

Full Income Statement

Balance Sheet

The company has 3.90 billion in cash and 12.53 billion in debt, giving a net cash position of -8.63 billion.

Cash & Cash Equivalents	3.90B
Total Debt	12.53B
Net Cash	-8.63B
Net Cash Per Share	n/a
Equity (Book Value)	-7.11B
Book Value Per Share	-33.80
Working Capital	3.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 920.71 million and capital expenditures -42.94 million, giving a free cash flow of 877.77 million.

Operating Cash Flow	920.71M
Capital Expenditures	-42.94M
Free Cash Flow	877.77M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.43%, with operating and profit margins of 12.90% and -1.46%.

Gross Margin	68.43%
Operating Margin	12.90%
Pretax Margin	-1.10%
Profit Margin	-1.46%
EBITDA Margin	13.41%
EBIT Margin	12.90%
FCF Margin	7.98%

Dividends & Yields

BMV:BCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.84%
Shareholder Yield	-1.84%
Earnings Yield	-0.55%
FCF Yield	3.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:BCRX has an Altman Z-Score of -1.89 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.89
Piotroski F-Score	6